# Metadoxine as a Therapy for Severe Alcoholic Hepatitis

> **NCT02161653** · PHASE4 · COMPLETED · sponsor: **Hospital General de Mexico** · enrollment: 135 (actual)

## Conditions studied

- Severe Alcoholic Hepatitis

## Interventions

- **DRUG:** Prednisone plus Metadoxine
- **DRUG:** Pentoxifylline plus Metadoxine

## Key facts

- **NCT ID:** NCT02161653
- **Lead sponsor:** Hospital General de Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2014-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02161653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02161653, "Metadoxine as a Therapy for Severe Alcoholic Hepatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02161653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*